GSK3B and cardiac hypertrophy: We and others previously revealed that several signaling pathways are involved in the regulation of cardiac hypertrophy, including the MAPK, calcineurin/nuclear factor of activated T cells (NFAT), and Akt/GSK-3β signaling cascades [14], [15], [17].